Deals

Counsyl bags $2.2M for pre-natal genetic testing

Counsyl, maker of DNA tests used to diagnose predispositions to genetic diseases in prospective parents before they conceive, has brought in $2.2 million in equity, according to a filing with the SEC. Based in Redwood City, Calif., the company raised $2.7 million in 2009 from 21 undisclosed investors. The company got a write-up in The New York Times at the end of January.